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Abstract
NF-kB signalling plays an essential role in T cell activation and generation of regulatory and memory populations in vivo.I n
the present study, we aimed to investigate the role of NF-kB signalling in post-activation T cells using tissue specific ablation
of inhibitor of kappa-B kinase 2 expression, an important component of the inhibitor of kappa-B kinase complex in
canonical NF-kB signalling. The OX40 antigen is expressed on activated T cells. Therefore, we used previously described
mouse strain expressing Cre recombinase from the endogenous OX40 locus. Ablation of IKK2 expression using OX40
Cre
mice resulted in the development of an inflammatory response in the skin epidermis causing wide spread skin lesions. The
inflammatory response was characterised by extensive leukocytic infiltrate in skin tissue, hyperplasia of draining lymph
nodes and widespread activation in the T cell compartment. Surprisingly, disease development did not depend on T cells
but was rather associated with an unanticipated expression of Cre in skin epidermis, and activation of the T cell
compartment did not require Ikbk2 deletion in T cells. Employment of Cre reporter strains revealed extensive Cre activity in
skin epidermis. Therefore, development of skin lesions was rather more likely explained by deletion of Ikbk2 in skin
keratinocytes in OX40
Cre mice.
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Introduction
The transcription factor NF- B regulates the expression of genes
controlling cell survival, proliferation, immune stress responses and
inflammatory reactions [1,2,3]. Canonical NF-kB signalling is
mediated by hetero- and homo-dimers of proteins belonging to the
NF-kB family. These dimers are held inactive in the cytoplasm by
inhibitor of kappa B (IkB) proteins. IkBs can be phosphorylated
and ubiquitinated as a result of signalling induced by multiple
stimuli including pro-inflammatory cytokines and antigen recep-
tors particularly the T cell receptor (TCR). These modifications
induce IkB degradation via the proteosome and translocation of
NF-kB subunits into the nucleus for regulation of transcription [4].
Phosphorylation of IkB is mediated by the IkB kinase (IKK)
complex, containing two catalytic subunits IKK1 (IKKa), IKK2
(IKKb) [5,6] and a regulatory subunit, NF-kB essential modulator
(NEMO or IKKc) [7,8]. While IKK1 and IKK2 are highly
homologous kinases, individual knockout mice produce different
phenotypes; IKK1 deficient mice die shortly after birth with
skeletal abnormalities and a thickened hyper proliferative
epidermis [9,10]. IKK2 knockout mice die at embryonic day
12.5–14.5 from a massive liver degeneration as a result of tumour
necrosis factor (TNF)-induced hepatocyte apoptosis [11,12,13].
NEMO is a catalytically inactive NF-kB modulator [7,8,14] and
knockout mice exhibit male embryonic lethality due to massive
hepatocyte apoptosis. In addition, heterozygote females develop
patchy skin lesions with massive granulocyte infiltration, hyper
proliferation and increased apoptosis of keratinocytes, reminiscent
of incontinentia pigmenti (IP), which has subsequently become an
animal model for this disease [15,16].
In T cells of the immune system, NEMO activity is required for
normal T cell activation. Perturbations to NF-kB signalling in T
cells either lacking the c-Rel subunit [17] or IKK2 [18], or in mice
expressing a knock-in mutation of p105 that is resistant to IKK
induced proteolysis [19], all result in impairment of TCR triggered
proliferation. In some cases, this could be attributed to a failure to
produce IL-2 [17,19]. These defects in activation are also
associated with defective T cell homeostasis, since these same
strains all lack normal memory and regulatory T cell populations.
However, whether this reflects a specific failure to either generate
or maintain these populations remains unclear.
In the present study, we aimed to investigate the role of NF-kB
signalling in maintenance of memory and regulatory CD4 T cell
populations by deleting IKK2 in mature T cells after their
activation. This was achieved using a previously described Cre
recombinase expressed from the endogenous OX40 gene locus
(OX40
Cre) [20]. OX40 is a member of the TNF receptor super
family whose expression was thought to be restricted to CD4 T
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deletion of a floxed Ikbk2 allele with OX40
Cre resulted in a severe
inflammatory phenotype characterised by development of skin
lesions with extensive haematopoietic infiltrate and immune
activation. Contrary to expectations, disease development did
not depend on Ikbk2 deletion in T cells, the anticipated site of
OX40
Cre expression, but was rather associated with Cre activity in
skin epidermis.
Results
Conditional deletion of Ikbk2 using OX40
Cre driver results
in severe skin pathology
In order to investigate the role of NF-kB activity in antigen
experienced peripheral T lymphocyte populations in vivo, we took
advantage of a previously described conditional allele of Ikbk2
where exons 6 and 7 are flanked by two loxP sites (Ikbk2
fx hereon)
[22]. Conditional deletion of Ikbk2 in T cells was achieved by
generating homozygote Ikbk2
fx/fx strain also carrying an insertion
of the gene for Cre recombinase in the Ox40 locus [20]. OX40 is a
member of the TNF receptor family of proteins induced upon T
cell activation [21] and also constitutively expressed on peripheral
Treg [23]. All mice were bred to express OX40
Cre in consideration
of Cre toxicity [24] and Ikbk2
fx/wt OX40
Cre mice, expressing a
single WT Ikbk2 allele, were bred as controls. Control Ikbk2
fx/wt
OX40
Cre mice were entirely healthy. Both strains were also
homozygous for the Rosa26RYFP Cre reporter allele (See
Materials and Methods). Unexpectedly, Ikbk2
fx/fx OX40
Cre mice
developed progressive skin lesions (Fig. 1A). Pathology was
characterised by hair loss and a dry, flaky appearance. In order
to grade disease severity, pathology was scored on the basis of the
proportion of the dorsal surface affected (Fig. 1A, Methods). At
late stages, mice with more than 50% involvement of the dorsal
surface also exhibited weight loss and were therefore culled. Time
course analysis of disease development revealed an onset of disease
at approximately 5–6 weeks of age, followed by progressive
degeneration of mouse health over subsequent weeks (Fig 1B).
Epidermal hypertrophy and inflammation in Ikbk2
fx/fx
OX40
Cre mice
To investigate the basis for the skin pathology in Ikbk2
fx/fx
OX40
Cre mice, we first analysed skin tissue samples by histology.
Skin sections from Ikbk
fx/fx OX40
Cre mice and Ikbk2
fx/wt OX40
Cre
controls were stained with haematoxylin and eosin, revealing
extensive epidermal hyperplasia and an increase in basal layer
keratinocytes in the epidermis (Fig. 2A). Ikbk2
fx/fx OX40
Cre mice
also showed several changes reminiscent of human psoriasis, such
as acanthosis, hyper- and parakeratosis as well as intraepithelial
and intra-hair follicle formation of aggregates of neutrophils and
macrophage (Fig. 2A).
We also analysed sections by confocal fluorescent microscopy.
Staining sections for expression of CD45 confirmed the presence
of an extensive leukocytic infiltrate in lesions (Fig. 2B). Cytokeratin
5 is highly expressed in mesothelium of basal layers in stratified
epithelia, and is a marker for mesothelioma and squamous cell
carcinoma [25,26,27,28,29]. Cytokeratin 6 is a lineage marker of
keratinocyte differentiation and is expressed in normal hair
follicles. Over expression of cytokeratin 6 in interfollicular
epidermis correlates with invasive tumour and can mark remnants
of destroyed hair follicles. Induction of cytokeratin 6 is also
commonly seen in hyper proliferative skin disorders and in wound
healing [30,31]. Staining sections for expression of cytokeratins 5
and 6 revealed elevated levels of both proteins in skin sections from
Ikbk2
fx/fx OX40
Cre mice (Fig. 2B). Cytokeratin 5 expression was
much enhanced at the epidermis of Ikbk2
fx/fx OX40
Cre mice and
highly induced in hair follicles compared to Ikbk2
fx/wt OX40
Cre
controls. Expression of cytokeratin 6, a marker for interfollicular
epidermal differentiation, was low in control hair follicles but
highly induced in Ikbk2
fx/fx OX40
Cre skin in both epidermis and
several epithelial cell aggregates in the dermis. These aggregates
may represent epidermal cysts that are remnants of destroyed hair
follicles. Taken together, cytokeratin 5 and 6 expression is
dramatically induced in skin lesions of Ikbk2
fx/fx OX40
Cre mice
suggesting conditions of hyper proliferation, loss of hair follicle
integrity and the possibility of wound healing deficiencies in these
mice.
Increased T cell activation in Ikbk2
fx/fx OX40
Cre mice
Since we had initially generated Ikbk2
fx/fx OX40
Cre mice in
order to analyse IKK2 function in activated T cells, it was possible
that the inflammatory skin condition was an autoimmune T cell
response resulting from the Ikbk2 deletion in T cells. We therefore
examined the gross phenotype of the T cells in mice for evidence
of perturbations to the homeostasis of this compartment. A more
detailed functional analysis of Ikbk2 deletion in T cells by OX40
Cre
Figure 1. Development of skin pathology in OX40
Cre Ikbk2
fx/fx
mice. (A) Photographs show dorsal aspect of OX40
Cre Ikbk2
fx/fx mice
with varying degrees of skin pathology. Scoring was established
according to extent of involvement of the dorsal surface: 0 - no
pathology, 1 - ,10% surface, 2 - 10–25% surface, 3 - .25% surface.
Mice with .50% dorsal skin involvement and/or weight loss .20%
were culled. (B) Graph shows average mouse score for OX40
Cre Ikbk2
fx/fx
mice over time (n=9).
doi:10.1371/journal.pone.0032193.g001
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preparation). However, here we examined T cell numbers,
phenotype and distribution in Ikbk2
fx/fx OX40
Cre mice to look
for evidence that T cells could be contributing to the observed skin
pathology. Upon dissection of mice, it was immediately evident
that lymph nodes draining the skin were enlarged in Ikbk2
fx/fx
OX40
Cre mice at 8 weeks of age (Fig. 3A). Therefore, analysis of
lymph nodes was partitioned into those nodes that received
afferent lymphatic drainage from skin, comprising cervical,
brachial and axillary LNs (collectively dLN) and the mesenteric
chain of lymph nodes (mLN) served by lymphatic vessels draining
the gut. Confirming macroscopic observations, total cellularity of
dLN recovered from Ikbk2
fx/fx OX40
Cre was far greater when
compared with Ikbk2
fx/wt OX40
Cre controls. On average, mLN
and spleen sizes were similar between strains (Fig. 3B). Counting
CD4 and CD8 T cell numbers in organs also revealed their
contribution to dLN hyperplasia in Ikbk2
fx/fx OX40
Cre mice.
Numbers of these T cell subsets in mLN and spleen remained
similar to controls (Fig. 3B). We then analysed the composition of
CD4 and CD8 T cells in dLN using CD44 and CD25 expression.
CD4 T cells from Ikbk2
fx/fx OX40
Cre mice had a substantial
increase in the proportion of CD44
hi CD25
lo effector/memory
phenotype cells, indicating greatly increased levels of immune
activation in these mice. In contrast, proportions of CD25
hi cells,
that are largely FoxP3
+ Treg but may also include recently
activated effectors, were similar between strains. Similarly, CD8 T
cells from Ikbk2
fx/fx OX40
Cre mice also contained an enlarge subset
of CD44
hi activated/memory phenotype cells, also suggestive of
increased levels of immune activation.
Development of skin pathology does not require T cells
Although Ikbk2
fx/fx OX40
Cre mice exhibited extensive leukocytic
infiltration in skin lesions and evidence of increased immune
activation in the T cell compartment, it remained unclear whether
this was cause or effect of the on going skin pathology. To ask
whether T cells were specifically required for development of skin
pathology, Ikbk2
fx/fx OX40
Cre mice were crossed onto a recombi-
nase-activating gene 1 deficient (Rag1) background. Development
of T lymphocytes in Rag1
2/2 mice is developmentally arrested in
the thymus as cells cannot rearrange T cell receptor genes and
therefore express mature TCR, essential for normal T cell
development. Therefore, these mice have no mature T cells.
Interestingly, Rag1
2/2 Ikbk2
fx/fx OX40
Cre mice developed skin
pathology that was very similar to their Rag1 expressing
counterparts (Fig. 4A). Basic histological analysis revealed
epithelial hyperplasia (Fig. 4B) similar to that described in Rag1
expressing mice (Fig. 2A). Similarly, confocal analysis of CD45,
cytokeratin 5 and cytokeratin 6 expression levels revealed a
comparable inflammatory phenotype to that described in the
presence of T cells (Fig. 4C). Interestingly, analysing disease
progression over time revealed that development of pathology in
Rag1
2/2 Ikbk2
fx/fx OX40
Cre mice was delayed, compared with
Rag1 expressing Ikbk2
fx/fx OX40
Cre mice (Fig. 4D). Mean time to
reach disease score 2 was statistically significant between the two
strains (Fig. 4E). Thus, T cells are not required for the
development of the skin pathology in Ikbk2
fx/fx OX40
Cre but there
was evidence that their presence could exacerbate the course of
pathology.
OX40-Cre targets deletion of IKK2 in skin epithelia
The anticipated target tissue for the activity of OX40
Cre was in
activated and regulatory CD4
+ T cells. However, development of
skin pathology in Rag1
2/2 Ikbk2
fx/fx OX40
Cre mice lacking T cells
suggested that pathology induced by OX40
Cre activity must be
mediated by gene deletion outside of the T cell compartment. We
therefore asked whether OX40
Cre was active within the skin tissue
itself, and whether this could account for the development of
disease in these mice. To facilitate this analysis, Ikbk2
fx/fx OX40
Cre
mice were additionally bred with a Rosa26R
EYFP Cre reporter
mouse. This strain carries a modified Rosa26 locus containing the
YFP gene with upstream trimeric TpA stop sequences flanked by
loxP recombination sites (R26R
EYFP) [32]. Cells that express Cre
will excise the TpA stop sequences thereby releasing YFP
expression, which persists both after cessation of Cre expression
and in any cellular progeny. We initially analysed YFP expression
in skin by stereo fluorescent microscopy (Fig. 5A). Both control
Ikbk2
fx/wt OX40
Cre R26R
EYFP and Ikbk2
fx/fx OX40
Cre R26R
EYFP
strains exhibited dense EYFP expression around hair follicles in
the skin. We then examined EYFP expression by confocal
fluorescent microscopy to more precisely determine the cellular
localisation of EYFP expression. In control Ikbk2
fx/wt OX40
Cre
R26R
EYFP mice a thin layer of EYFP expression was localized to
the epidermis (Fig. 5B). Analysis of skin from Ikbk2
fx/fx OX40
Cre
Figure 2. OX40
Cre Ikbk2
fx/fx mice exhibit skin epidermis hyper-
plasia. (A) Images show skin sections from 12–16 wk old mice of the
indicated strain stained with H&E and taken at 106 magnification.
White dotted line indicates the border between dermis and epidermis.
(B) Confocal images of skins sections from 12–16 week old mice of the
indicated mice stained for expression of CD45, cytokeratin 5 or
cytokeratin 6 (red) and counter stained with DAPI. White scale bar
indicates 10 mm size. Data are representative of 3 independent
experiments and at least two mice per strain experiment.
doi:10.1371/journal.pone.0032193.g002
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EYFP mice also showed eYFP expression in the epidermis
that was more extensive than in controls (Fig. 5B), consistent with
the enlarged epidermis in these mice (Fig. 2A). Interestingly, more
detailed analysis of healthy control Ikbk2
fx/wt OX40
Cre R26R
EYFP
mice revealed that EYFP expression extended into hair follicles,
and was most brightly expressed in cellular structures in the bulb
of the hair follicle. Since EYFP expression does not necessarily
report current expression of OX40
Cre, we also attempted to
directly assess expression of OX40 in skin by immunostaining.
Staining could not reveal OX40 antigen expression in any samples
(data not shown). However, this may represent a limit on detection
with the mAb used, rather than a genuine absence of OX40
protein expression.
Immune activation in Ikbk2
fx/fx OX40
Cre mice is
independent of IKK2 deletion in T cells
The presence of EYFP expression in skin epidermis demon-
strated that OX40
Cre is active in skin epithelia, as well as in
activated T cells as previously reported [20]. Since development of
skin pathology occurred in the absence of T cells in Rag1
2/2
Ikbk2
fx/fx OX40
Cre mice, we also questioned whether the immune
activation observed in the T cells of Ikbk2
fx/fx OX40
Cre mice was
dependent on Ikbk2 deletion in the T cell compartment or was
rather a secondary phenotype induced by the on going
pathological processes in the skin. Evidence for the latter view
already comes from the observation that dLN in Ikbk2
fx/fx
OX40
Cre mice were specifically enlarged, implying that immune
activation was triggered by processes in the skin rather than being
a generalised phenotype throughout the T cell compartment of
these mice. However, to directly test whether immune activation
depended on OX40
Cre mediated IKK2 deletion in T cells, we
examined the behaviour of WT T cells transferred to either
Rag1
2/2 Ikbk2
fx/fx OX40
Cre or healthy Rag1
2/2 Ikbk2
fx/wt
OX40
Cre control mice. Because these strains are T cell deficient
and therefore profoundly lymphopenic, we adoptively transferred
high doses of T cells into recipients to minimise induction of
homeostatic proliferative responses that can also result in
generation of CD44
hi activated/memory phenotype cells [33].
Two weeks after cell transfer, dLN, mLN and spleen were
recovered from recipient mice and analysed by FACS. Both CD4
+
and CD8
+ WT donor T cells from dLN of Rag1
2/2 Ikbk2
fx/fx
OX40
Cre mice exhibited signs of immune activation compared
with the same WT donor T cells transferred to healthy Rag1
2/2
Ikbk2
fx/wt OX40
Cre mice. There was a substantial increase in
proportion CD44
hi activated/memory phenotype cells in both
CD4 and CD8 compartments (Fig. 6A). Interestingly, CD4
+
CD25
+ cells were also increased in representation amongst WT
donor T cells recovered from Rag1
2/2 Ikbk2
fx/fx OX40
Cre mice.
Calculating absolute numbers of CD4 and CD8 T cells in different
lymphoid organs revealed a specific accumulation of both subsets
in dLN but not mLN or spleen from Rag1
2/2 Ikbk2
fx/fx OX40
Cre
mice, resembling the dLN hyperplasia observed in intact Ikbk2
fx/fx
OX40
Cre mice (Fig. 3). Therefore, the immune activation
observed in Ikbk2
fx/fx OX40
Cre appears to be a characteristic
intrinsic to the host environment in Ikbk2
fx/fx OX40
Cre mice and
not the T cell compartment, suggesting that the skin pathology is
responsible for inducing the observed T cell response.
Skin pathology is associated with TNF-a production in
skin of Ikbk2
fx/fx OX40
Cre mice
The skin pathology we report here closely resembles that
reported in mice where Ikbk2 is conditionally deleted in skin
keratinocytes using the constitutive K14
Cre and inducible
K14
CreERT2 driver strains [31,34]. From these studies it can be
concluded that adult keratinocytes deficient in IKK2 aberrantly
produce inflammatory mediators driving skin pathology, indepen-
dently of developmental processes in the skin. This skin pathology
was hallmarked by epidermal hyperplasia, enhanced TNF
expression and increased cell death. The role of TNF in
pathophysiology of disease was illustrated in TNF receptor
deficient mice, in which the skin pathology resolves. These studies
propose that keratinocytes are sensitive to TNF induced death in
the absence of IKK2 dependent pro-survival signals. To see
whether a similar mechanism could account for the pathology we
observed in Ikbk2
fx/fx OX40
Cre mice, we analysed skin samples for
evidence of elevated TNF production and apoptosis. Significantly,
analysing skin samples by confocal fluorescent microscopy
revealed extensive TNF production throughout the dermis of
Ikbk2
fx/fx OX40
Cre mice not observed in controls (Fig. 7A). We
also analysed Rag1
2/2 Ikbk2
fx/fx OX40
Cre mice for TNF
expression. Surprisingly, TNF levels were much reduced in
Rag1
2/2 mice (Fig. 7B). The difference in TNF levels also
correlated with rate of disease onset, which was more rapid in
Ikbk2
fx/fx OX40
Cre mice than Rag1 deficient counterparts
(Figure 4D). We then assessed the level of apoptosis in skin
sections by TUNNEL assay. Significantly, examining skin from
Ikbk2
fx/fx OX40
Cre mice revealed evidence of high levels of
apoptosis throughout the dermis and epidermis (Fig. 7C).
Discussion
In the present study, we employed an OX40
Cre driver mouse
line in order to delete IKK2 in T cells post activation.
Unexpectedly, mice developed a severe and progressive inflam-
matory skin condition characterised by epidermal hyperplasia,
leukocytic infiltrate and extensive T cell activation in draining
lymph nodes. Although pathology superficially resembled an
autoimmune response, disease was found not to depend on either
T cells or deletion of the Ikbk2 gene in activated T cells, but rather
the unforeseen deletion of IKK2 in skin epithelia by the OX40
Cre
driver.
The role of NF-kB signalling in skin epithelial homeostasis has
previously been investigated by tissue specific deletion of Ikbk2
using K14-Cre driver [31,34]. These mice developed severe skin
pathology similar to that observed in the present study. In both
cases, skin inflammation was associated with extensive leukocytic
infiltration; epithelial hyperplasia enhanced production of TNF
and increased levels of apoptosis. The K14 promoter drives Cre
expression in keratinocytes within skin epithelium. Using
R26RYFP reporter strain mice allowed us to map the extent of
Cre activity in OX40
Cre mice. We found extensive YFP expression
Figure 3. Lymphoid hyperplasia and T cell activation in OX40
Cre Ikbk2
fx/fx mice. (A) Images show axillary and brachial lymph nodes (top four
nodes) as compared with mesenteric chain and spleen from the indicated mouse strains, taken between 12–16 weeks of age. (B) Scatter charts show
absolute numbers of total lymphocytes, CD4
+ TCR
hi or CD8
+ TCR
hi T cells in skin draining lymph nodes (dLN), mesenteric lymph nodes (mLN) or
spleen (SPN) in OX40
Cre Ikbk2
fx/fx mice (fx/fx, n=6) or control OX40
Cre Ikbk2
fx/wt mice (fx/wt, n=4). (C) Density plots are of CD25 vs CD44 expression by
CD4
+ TCR
hi T cells (top row) and side scatter (SSC) vs CD44 by CD8
+ TCR
hi T cells (bottom row) from dLN of the indicated mouse strains. Data are
representative of six independent experiments.
doi:10.1371/journal.pone.0032193.g003
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similarly extensive deletion of Ikbk2 in the same tissue. The
development of skin pathology comparable to that observed in
K14-Cre Ikbk2
fx/fx mice suggests that there was extensive deletion
of IKK2 in these same cells. It remains unclear however whether
OX40
Cre is expressed constitutively in skin epithelial cells or
whether it is expressed only at a specific developmental stage. In
this regard, the extensive YFP expression in hair follicles may be
significant, since this is also thought to be the site of origin of stems
cells for skin epithelia [35,36,37].
Attempts to detect OX40 protein expression in skin were
unsuccessful. It is possible that the antibody reagents were not
sufficiently sensitive to detect the levels of OX40 potentially
Figure 4. Skin pathology in OX40
Cre Ikbk2
fx/fx mice is not T cell
dependent. (A) Photograph shows skin pathology in a representative
Rag1
2/2 OX40
Cre Ikbk2
fx/fx mouse (fx/fx) compared with a littermate
Rag1
2/2 OX40
Cre Ikbk2
fx/wt control (fx/wt). White dotted line indicates
the border between dermis and epidermis. (B) Images show skin
sections from 12–16 week old mice of the indicated strain stained with
H&E and taken at 106 magnification. (C) Confocal images of skins
sections from 12–16 week old mice of the indicated mice stained for
expression of CD45, cytokeratin 5 or cytokeratin 6 (red) and counter
stained with DAPI. White scale bar indicates 10 mm size. (D) Graph
shows progress of disease development in Rag1
2/2 OX40
Cre Ikbk2
fx/fx
mice (blue, n=18) as compared with Rag1 sufficient OX40
Cre Ikbk2
fx/fx
mice (black lines, n=9). (E) Bar chart shows mean time of disease
progression to score 2 in Rag1
2/2 OX40
Cre Ikbk2
fx/fx mice as compared
with Rag1 sufficient OX40
Cre Ikbk2
fx/fx mice. Data are representative (A–
C) of three independent experiments or are pooled (D–E) from three
independent experiments.
doi:10.1371/journal.pone.0032193.g004
Figure 5. Cre EYFP reporter expression in the skin of OX40
Cre
strains. (A) Fluorescent stereomicroscope images of epidermal skin
layer taken from the underside (610 magnification). (B) Confocal
images of skins sections from 12–16 week old mice of the indicated
mice showing expression of EYFP and counter stained with DAPI. (C)
EYFP expression in hair follicle of healthy OX40
Cre Ikbk2
fx/wt mice
showing DAPI and EYFP separately and together. White scale bar
indicates 10 mm size. Data are representative of five or more mice from
three independent experiments.
doi:10.1371/journal.pone.0032193.g005
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limited to transient expression in a rare epithelial stem cell
precursor population. In future studies, it would be interesting to
compare the pattern of Cre activity between OX40
Cre and
K14
Cre, since K14 expression may be restricted to more
differentiated stages of keratinocyte development, and OX40
Cre
may represent a tool to target skin epithelia progenitors. However,
until these studies are performed, this remains a point of
Figure 6. Activation of WT T cells in Rag1
2/2 OX40
Cre Ikbk2
fx/fx mice. Eight week old Rag1
2/2 OX40
Cre Ikbk2
fx/fx and Rag1
2/2 OX40
Cre Ikbk2
fx/wt
controls were reconstituted with 5610
7 lymph node T cells from WT C57Bl6
NIMR mice. Two weeks later, number and phenotype of transferred T cells
in different recipients was determined. (A) Contour plots are of CD25 vs CD44 expression by CD4
+ TCR
hi T cells (top row) and side scatter (SSC) vs
CD44 by CD8
+ TCR
hi T cells (bottom row) from dLN of Rag1
2/2 OX40
Cre Ikbk2
fx/fx (Ikbk2 fx/fx) and Rag1
2/2 OX40
Cre Ikbk2
fx/wt (Ikbk2 fx/wt) hosts.
Numbers indicate % of cells in the adjacent gate. Data are representative of at least five mice per strain. (B) Scatter charts show absolute numbers of
CD4
+ TCR
hi or CD8
+ TCR
hi T cells in skin draining lymph nodes (dLN), mesenteric lymph nodes (mLN) or spleen (SPN) in host Rag1
2/2 OX40
Cre Ikbk2
fx/fx
mice (fx/fx) or control Rag1
2/2 OX40
Cre Ikbk2
fx/wt mice (fx/wt). Data are pool of two independent experiments.
doi:10.1371/journal.pone.0032193.g006
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Cre cDNA, a bacterial gene, to the endogenous OX40 locus
caused the ectopic expression of the OX40 locus in skin epithelial
tissues. Until endogenous OX40 gene expression is detected in
skin epithelial cells, this possibility cannot be ruled out. Previous
studies have detected OX40 transcription in a wide range of
tissues, including lung, skeletal and heart muscle, and testis [38],
while others report expression in leukocytes other than T cells,
such as NK cells. Consistent with this, a small (,1%) but
detectable population of YFP
+ TCR
2 leukocytes was apparent in
lymphoid tissues (Cornish et al, in preparation). We could confirm
that OX40
Cre was active in the male germline, as offspring of
OX40
Cre males frequently resulted in non-specific activation of the
YFP reporter in the absence of OX40
Cre allele in offspring, as
reported previously [20]. While we cannot exclude the possibility
that introduction of the Cre gene to the endogenous OX40 locus
has in some way perturbed normal gene expression resulting in
ectopic expression in skin epithelia, we can confirm that OX40
Cre
does faithfully report OX40 activity at least in T cells and testis as
previously reported. The activity of OX40
Cre within skin epithelia
may be relevant for both past [39,40,41,42] and future studies
using this driver to induce tissue specific gene deletion, especially
in the light of the impact of dysregulated skin homeostasis on the
normal T cell compartment. Whether OX40
Cre drives deletion in
other tissues reported to express OX40 remains to be determined.
The potential physiological role of OX40 gene activity in skin
epithelium is unclear. However, there are no reports of skin
abnormalities in OX40 deficient mice, so it does not appear that
there is a non-redundant role for OX40 in the homeostasis of
normal skin epithelia. Never the less, the OX40
Cre line employed
in the present study mediated very efficient deletion of loxP-
flanked genes in skin epidermis.
Our study also demonstrates how inflammatory processes can
result in profound activation of the adaptive immune system, even
in the apparent absence of foreign antigen. Our original aim had
been to study the role of IKK2 signalling in activated T cells using
Ikbk2
fx/fx OX40
Cre mice. Therefore, when we observed the
development of skin inflammation that was associated with
substantial local activation of T cells in draining lymph nodes, it
was natural to suppose that this was a consequence of the T cell
specific deletion of Ikbk2. However, we found this was not the case.
Skin pathology did not depend on the presence of T cells in
Rag1
2/2 Ikbk2
fx/fx OX40
Cre mice, although disease development
was significantly slower in this strain. Furthermore, immune
activation similar to that in intact Ikbk2
fx/fx OX40
Cre mice was
observed when Rag1
2/2 Ikbk2
fx/fx OX40
Cre mice were reconsti-
tuted with WT T cells, so did not require Ikbk2 deletion in T cells.
Indeed, the resulting skin condition was rather exacerbated by the
transfer of WT T cells for just 2 weeks (data not shown) compared
with intact Ikbk2
fx/fx OX40
Cre mice. This observation is also
consistent with the elevated levels of TNF detected in Ikbk2
fx/fx
OX40
Cre as compared with the Rag1
2/2 Ikbk2
fx/fx OX40
Cre
strain. The presence of T cells in mice clearly exacerbated TNF
production in the skin. This could either have been a result of
direct production by T cells or an indirect consequence of T cells
on inflammatory cells such as macrophages. Previous studies
demonstrated the importance of TNF for pathology by rescuing
mice from pathology by the introduction of Tnfr1 deficiency [34].
Future studies could use a similar strategy to confirm the
importance of TNF signalling in Rag1
2/2 Ikbk2
fx/fx OX40
Cre
mice, especially as TNF levels were clearly lower in these mice
than the T cell sufficient strain. In other studies, haematopoietic
reconstitution of WT mice with bone marrow from Ikbk2
fx/fx
OX40
Cre donors resulted in normal T cell reconstitution and
recipients showed no sign of the skin inflammation observed in
intact Ikbk2
fx/fx OX40
Cre donors (Cornish et al, in preparation).
Thus, restricting Ikbk2 deletion to the haematopoietic system is not
sufficient to induce skin pathology. Furthermore, the activation
within the T cell compartment of Ikbk2
fx/fx OX40
Cre mice does
Figure 7. Skin pathology in OX40
Cre Ikbk2
fx/fx mice is associated
with TNF production and increased apoptosis. (A) Confocal
images of skins sections from 12–16 week old mice of the indicated
strain were analysed for EYFP expression (green), stained with DAPI
(blue) and for expression of TNF (red). White scale bar indicates 10 mm
size. (B) Apoptosis was assessed in skin sections from OX40
Cre Ikbk2
fx/fx
and OX40
Cre Ikbk2
fx/wt mice by TUNNEL assay and counterstained with
eosin. Light microscopy was performed at 106magnification.
doi:10.1371/journal.pone.0032193.g007
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secondary to the on going inflammatory process in the skin.
It remains to be determined what is driving the extensive
immune activation observed in Ikbk2
fx/fx OX40
Cre mice. The
enlargement of draining lymph nodes is likely to be in part due to
increased trafficking of cells into lymph nodes in response to
inflammatory mediators, which are known to increase permeabil-
ity of high endothelial venules that serve lymph nodes. However,
such recruitment cannot account for the substantial increase in
CD44
hi activated/memory phenotype cells in both CD4 and CD8
subsets that must in part be the result of activation and expansion
of naı ¨ve precursors. It remains to be determined whether the
expansion is antigen specific or the result of altered T cell
homeostasis secondary to the effects of inflammatory mediators on
dendritic and stromal cell components of the lymph node that are
sources of IL-15 and IL-7 respectively [43,44,45] required for
memory cell homeostasis. If the response is antigen specific, it will
be interesting to investigate whether activation is in response to
foreign antigen, such as environmental bacteria that have infected
following the breakdown of skin epithelial barrier, or whether the
response to altered self presentation by antigen presenting cells
trafficking from the inflamed tissue. The answers to these questions
could have important implications for understanding how the T
cell compartment as a whole reacts to inflammatory processes.
Materials and Methods
Mice
Mice used in this study were: Ikbk2
fx/fx [22], OX40
cre
recombinase [20]; Rosa26RYFP [32], C57Bl6/J.Rag1
2/2,
C57Bl/6
NIMR. OX40
Cre transmission was restricted to female
mice as OX40 is expressed in testis [20]. All Ikbk2
fx OX40
Cre
strains used in this study were also homozygous for the
Rosa26RYFP allele. Mice were bred and maintained at the
National Institute for Medical Research. Mice were bred and
maintained at the MRC National Institute for Medical Research.
Experiments were performed according to U.K. Home Office
regulations. The study was conducted under Project License 80/
2092 that has been approved by both the NIMR Ethical Review
Panel and the U.K. Home Office.
Pathology
Microscopic pathological assessment of embedded skin sections
was conducted by Dr Madhuri Warren, Pathology Diagnostics,
Cambridge, U.K. Whole live mouse pathology scoring was carried
out at the NIMR under the following criteria, assessing the level of
involvement of the dorsal surface; 0=no hair loss; 1=1–10% hair
loss; 2=10–25% hair loss and may include dermatitis and itching,
3.25% hair loss and may include dermatitis, itching, reddening
skin, reduced weight. An endpoint was defined as meeting any of
the following criteria; .50% hair loss, any signs of weakness or
distress, or weight loss .20% starting.
Immunofluorescence
Mice were shaved free of long hair, skin harvested, fixed in 4%
paraformaldehyde for 2 hr and transferred into 30% sucrose
rotating overnight at 4uC. Samples were then embedded in OCT
compound and frozen. 25 mm cryostat sections were cut and
mounted on slides for immuno-staining. The cryostat sections were
left to air dry for 1 hour in the dark then transferred to 220uC
freezer until staining. Frozen sections were taken from the freezer
and left at room temp for 2 mins, incubated in PBS for 5 mins and
permeabilized with 0.1% triton-X for 30 min at room temp. Slides
were incubated firstly with mouse serum for 30 mins at room temp
in a humid chamber and then purified antibodies re-suspended in
PBS for 1 hr at RT at the following concentrations: Rabbit anti-
mouse CD45 (14-0451-82, eBioscience) 1/50; Rabbit anti-mouse
Cytokeratin 5 (ab24647-50, Abcam) 1/200; Rabbit anti-mouse
Cytokeratin 6 (ab24646-50, Abcam) 1/200; Rabbit anti-mouse
TNF-alpha (14-7321-85, eBioscience) 1/20. Rabbit antibodies
were detected with goat anti-rabbit IgG AF546 (A-11010 10 mg/
mL Molecular Probes) or Goat anti-rat IgG (H+L) AF647 (A21247
10 mg/mL Molecular Probes) for 1 hr in a dark humid chamber at
RT re-suspended in PBS. All slides were counter stained with
1.5 ug/ml DAPI vectashield mounting medium (H-1200 Vector
Laboratories). Apoptosis was detected in paraffin embedded skin
sections using DERMATacs tunnel staining kit (Trevigen) as per
manufacturers instructions.
Flow cytometry
Phycoerythrin (PE)-conjugated monoclonal antibody (mAb)
against CD8; Texas Red (TR)-conjugated mAb against CD4; PE-
Cy5-conjugated mAb against TCRb; PE-Cy7-conjugated mAb
against CD25; Pacific Blue (PB)-conjugated mAb against CD44.
Flow cytometry was performed with 2610
6 lymph node cells and
splenocytes harvested and disassociated in air-buffered IMDM 10%
FCS at 4uC. Cell concentrations were determined by a Scharf
Instruments Casy Counter. Cells were incubated with saturating
concentrations of antibodies in 100 ml of phosphate-buffered saline
(PBS), 0.1% bovine serum albumin (BSA), 1 mM sodium azide
(PBS-BSA-azide) for 1 hour at 4uC followed by one wash in PBS-
BSA-azide.Seven-colourcytometricstaining wasanalysed onCyAn
instruments (Dako), and data analysis and colour compensation
were performed with FlowJo V9 software (TreeStar). The data are
presented on log and biexponential displays.
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